Blackstone Life Sciences Advisors

Private Equity SEC-registered adviser

Legal name: Blackstone Life Sciences Advisors L.L.C.

AUM

$13.2B

Regulatory AUM

Private funds

Private Equity 6 · Other 3

Private fund assets

$13.2B

Gross asset value

Employees

Last Form D raise

Apr 2026

Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(2)

Owners and executive officers named on the firm's SEC Form ADV.

Global Head of Private Equity

Global Head of Life Sciences

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

Fund	Type	Gross assets	Raised (Form D)	Investors	Last Form D	Recency
Blackstone Life Sciences VI L.P.	Private Equity	$3.8B	$6.3B	119	Apr 2026	Warm
Blackstone Life Sciences VI (lux) Scsp	Private Equity	$372.8M	$6.3B	23	Apr 2026	Warm
Blackstone Life Sciences VI - B L.P.	Private Equity	$163.0M	$6.3B	1	Apr 2026	Warm
Blackstone Life Sciences VI - Bl L.P.	Private Equity	$88.2M	$6.3B	1	Apr 2026	Warm
Blackstone Life Sciences Yield Nt L.P.	Other	$859.4M	$1.6B	27	Apr 2022	Cold
Blackstone Life Sciences Yield T L.P.	Other	$383.2M	$1.6B	6	Apr 2022	Cold
Blackstone Life Sciences Yield L.P	Other	$376.5M	$1.6B	11	Apr 2022	Cold
Blackstone Life Sciences V L.P.	Private Equity	$6.6B	$4.6B	102	Jul 2020	Cold
Blackstone Life Sciences V (lux) Scsp	Private Equity	$587.4M	$4.6B	20	Jul 2020	Cold

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.